【レポートの概要（一部）】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Parent market
• Market characteristics
• Value Chain Analysis
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market Outlook
• Market size and forecast 2019-2024
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY TYPE
• Market segmentation by type
• Comparison by type
• Multivalent conjugate vaccine – Market size and forecast 2019-2024
• Monovalent conjugate vaccine – Market size and forecast 2019-2024
• Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Increasing research activities for novel conjugate vaccine development
• Emergence of strategies to improve conjugate vaccine manufacturing
• Increasing efforts for stockpiling of conjugate vaccines
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Aurobindo Pharma Ltd.
• GlaxoSmithKline Plc
• Integrated Biotherapeutics Inc.
• Merck & Co. Inc.
• Mitsubishi Tanabe Pharma Corp.
• Pfenex Inc.
• Pfizer Inc.
• Sanofi
• Serum Institute of India Pvt. Ltd.
• Sun Pharmaceutical Industries Ltd.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Type – Market share 2019-2024 (%)
Exhibit 19: Comparison by type
Exhibit 20: Multivalent conjugate vaccine – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Multivalent conjugate vaccine – Year-over-year growth 2020-2024 (%)
Exhibit 22: Monovalent conjugate vaccine – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Monovalent conjugate vaccine – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by type
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Top 3 countries in North America
Exhibit 31: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 33: Top 3 countries in Europe
Exhibit 34: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 36: Top 3 countries in Asia
Exhibit 37: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 38: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 39: Top 3 countries in ROW
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Aurobindo Pharma Ltd. – Vendor overview
Exhibit 49: Aurobindo Pharma Ltd. – Business segments
Exhibit 50: Aurobindo Pharma Ltd. – Organizational developments
Exhibit 51: Aurobindo Pharma Ltd. – Geographic focus
Exhibit 52: Aurobindo Pharma Ltd. – Key offerings
Exhibit 53: Aurobindo Pharma Ltd. – Key customers
Exhibit 54: GlaxoSmithKline Plc – Vendor overview
Exhibit 55: GlaxoSmithKline Plc – Business segments
Exhibit 56: GlaxoSmithKline Plc – Organizational developments
Exhibit 57: GlaxoSmithKline Plc – Geographic focus
Exhibit 58: GlaxoSmithKline Plc – Segment focus
Exhibit 59: GlaxoSmithKline Plc – Key offerings
Exhibit 60: GlaxoSmithKline Plc – Key customers
Exhibit 61: Integrated Biotherapeutics Inc. – Vendor overview
Exhibit 62: Integrated Biotherapeutics Inc. – Business segments
Exhibit 63: Integrated Biotherapeutics Inc. – Key offerings
Exhibit 64: Integrated Biotherapeutics Inc. – Key customers
Exhibit 65: Merck & Co. Inc. – Vendor overview
Exhibit 66: Merck & Co. Inc. – Business segments
Exhibit 67: Merck & Co. Inc. – Organizational developments
Exhibit 68: Merck & Co. Inc. – Geographic focus
Exhibit 69: Merck & Co. Inc. – Segment focus
Exhibit 70: Merck & Co. Inc. – Key offerings
Exhibit 71: Merck & Co. Inc. – Key customers
Exhibit 72: Mitsubishi Tanabe Pharma Corp. – Vendor overview
Exhibit 73: Mitsubishi Tanabe Pharma Corp. – Business segments
Exhibit 74: Mitsubishi Tanabe Pharma Corp. – Organizational developments
Exhibit 75: Mitsubishi Tanabe Pharma Corp. – Geographic focus
Exhibit 76: Mitsubishi Tanabe Pharma Corp. – Key offerings
Exhibit 77: Mitsubishi Tanabe Pharma Corp. – Key customers
Exhibit 78: Pfenex Inc. – Vendor overview
Exhibit 79: Pfenex Inc. – Business segments
Exhibit 80: Pfenex Inc. – Organizational developments
Exhibit 81: Pfenex Inc. – Key offerings
Exhibit 82: Pfenex Inc. – Key customers
Exhibit 83: Pfizer Inc. – Vendor overview
Exhibit 84: Pfizer Inc. – Business segments
Exhibit 85: Pfizer Inc. – Organizational developments
Exhibit 86: Pfizer Inc. – Geographic focus
Exhibit 87: Pfizer Inc. – Segment focus
Exhibit 88: Pfizer Inc. – Key offerings
Exhibit 89: Pfizer Inc. – Key customers
Exhibit 90: Sanofi – Vendor overview
Exhibit 91: Sanofi – Business segments
Exhibit 92: Sanofi – Organizational developments
Exhibit 93: Sanofi – Geographic focus
Exhibit 94: Sanofi – Segment focus
Exhibit 95: Sanofi – Key offerings
Exhibit 96: Sanofi – Key customers
Exhibit 97: Serum Institute of India Pvt. Ltd. – Vendor overview
Exhibit 98: Serum Institute of India Pvt. Ltd. – Product segments
Exhibit 99: Serum Institute of India Pvt. Ltd. – Organizational developments
Exhibit 100: Serum Institute of India Pvt. Ltd. – Key offerings
Exhibit 101: Serum Institute of India Pvt. Ltd. – Key customers
Exhibit 102: Sun Pharmaceutical Industries Ltd. – Vendor overview
Exhibit 103: Sun Pharmaceutical Industries Ltd. – Business segments
Exhibit 104: Sun Pharmaceutical Industries Ltd. – Organizational developments
Exhibit 105: Sun Pharmaceutical Industries Ltd. – Geographic focus
Exhibit 106: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibit 107: Sun Pharmaceutical Industries Ltd. – Key customers
Exhibit 108: Validation techniques employed for market sizing
Exhibit 109: Definition of market positioning of vendors
【レポート販売概要】
■ タイトル：コンジュゲートワクチンの世界市場：種類別、地域別■ 英文：Conjugate Vaccines Market by Type and Geography - Forecast and Analysis 2020-2024
■ 発行日：2019年12月10日
■ 調査会社：Technavio
■ 商品コード：IRTNTR40714
■ 調査対象地域：グローバル
- 世界のパスタ・麺市場動向：企業M&A（2014年5月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global pasta & noodles market during May 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global pasta & noodles market throughout the month. Additionally, the report provides an overview of all …
- 褐色細胞腫（Pheochromocytoma）：グローバル臨床試験レビュー（2014年上半期）Pheochromocytoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Pheochromocytoma Global Clinical Trials Review, H1, 2014" provides data on the Pheochromocytoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pheochromocytoma. It includes an overview of the trial numbers and their recruitment statu …
- GeoPetro Resources Company：石油・ガスの開発・生産動向及びコスト分析- 2012GeoPetro Resources Company Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary GeoPetro Resources Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- 世界の金融産業における静脈認証（生体認証）市場：指静脈認証、手のひら静脈認証About vein recognition biometrics in BFSI sector The demand for highly reliable and accessible personal authentication and identification systems is increasing in the BFSI sector because of the growing instances of security vulnerabilities and transactional fraudulent in this sector. Biometrics is a suitable and reliable solution as it is based on the behavioral and physiological characteristics o …
- 食品安定剤（調合・組成）の世界市場予測（～2023年）“The food stabilizers (blends & systems) market is projected to grow at a CAGR of 4.0%, and the key drivers included growing consumption of processed food, the multifunctionality of food stabilizers, and the increased use of natural ingredients.” The food stabilizers (blends & systems) market is estimated at USD 2.3 billion in 2018, and projected to grow at a CAGR of 4.0%, to reach USD 2.8 billion …
- KenyaのCarpets and Other Textile Floor Coverings市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Kenya and its perspectives on the global market for Carpets and other textile floor сoverings. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on Carpets and other textile floor сoverings export/import operations …
- 道路安全ソリューションの世界市場予測（～2023年）The road safety market size is expected to grow at a CAGR of 9.8% during the forecast period.The road safety market size is expected to grow from USD 2.76 billion in 2018 to USD 4.41 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 9.8% during the forecast period. Rapid urbanization, increasing number of vehicles across the globe, rising need for road safety owing to increasing number o …
- イギリスの自動微生物検査市場2014Complete report $6,950. DataPack (test volumes, sales forecasts, supplier shares) $4,500. “UK Automated Microbiology Market 2014” is a new analysis of major business opportunities emerging in the U.K. automated microbiology market during the next five years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovati …
- 対麻痺治療のグローバル臨床試験動向（2014年H1）Paraplegia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Paraplegia Global Clinical Trials Review, H1, 2014" provides data on the Paraplegia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Paraplegia. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
- ワイヤレス機内エンターテイメント（W-IFE）の世界市場：機体別（ナローボディ、ワイドボディ、リージョナルジェット）、取り付け別（レトロフィット、ラインフィット）、ハードウェア別、技術別、地域別予測Global Wireless In-Flight Entertainment (W-IFE)s Market to reach USD 3.6 billion by 2025. Global Wireless In-Flight Entertainment (W-IFE)s Market valued approximately USD 920 Million in 2016 is anticipated to grow with a healthy growth rate of more than 16.40% over the forecast period 2017-2025. Wireless In Flight Entertainment Market is expected to witness substantial growth over the next eight y …
- RFIDリーダーの世界市場2016-2020RFID readers play a critical role in inventory management and are finding tremendous response in many big stores, supermarkets, hypermarkets, and apparel stores. This market research report by Technavio emphasizes on the involvement of RFID readers in different end-user segments like healthcare, transportation, and retail. The increasing incorporation of RFID readers in these segments is expected …
- 民間航空機用健全性監視システム（AHMS）の世界市場ABSTRACTAbout Commercial Aircraft Health Monitoring Systems Aircraft health monitoring systems (AHMS) collect data in real time from the aircraft fleet and make it available to ground operations. Various sensors are installed at various damage hotspots throughout aircraft structure/engine, which provide an early detection of anomaly (or initiation of crack/fatigue). Thus, necessary preventive meas …
- 世界主要国における大腸菌検査市場2015The report contains 200 pages, 7 tables and presents a detailed analysis of the E. Coli diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the E. Coli definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospit …
- 腸癌(Intestinal Cancer)：世界の治験レビュー（2015年上半期版）Intestinal Cancer Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Intestinal Cancer Global Clinical Trials Review, H1, 2015" provides data on the Intestinal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Intestinal Cancer. It includes an overview of the trial numbers and their recruitment s …
- 世界のエチレン産業動向Global Ethylene Industry - Feedstock Advantage Shifts New Investments to the US Summary GlobalData, the industry analysis specialist, has released its latest research, “Global Ethylene Industry - Feedstock Advantage Shifts New Investments to the US”. The study comes from the company’s oil and gas research group and provides market analysis of the global ethylene industry, highlighting major featur …
